Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Sales

NewGenIvf (NIVF) EBITDA Margin: 2021-2024

Historic EBITDA Margin for NewGenIvf (NIVF) over the last 4 years, with FY2024 value amounting to 8.13%.

  • NewGenIvf's EBITDA Margin fell 194744540600.0% to 19474473.52% in Q3 2025 from the same period last year, while for Sep 2025 it was 5729778.42%, marking a year-over-year change of. This contributed to the annual value of 8.13% for FY2024, which is 98000.0% down from last year.
  • As of FY2024, NewGenIvf's EBITDA Margin stood at 8.13%, which was down 98000.0% from 1.67% recorded in FY2023.
  • NewGenIvf's 5-year EBITDA Margin high stood at 2.25% for FY2022, and its period low was 8.13% during FY2024.
  • In the last 4 years, NewGenIvf's EBITDA Margin had a median value of 0.75% in 2021 and averaged 1.85%.
  • In the last 5 years, NewGenIvf's EBITDA Margin soared by 54300bps in 2022 and then crashed by -98000bps in 2024.
  • NewGenIvf's EBITDA Margin (Annual) stood at 3.18% in 2021, then skyrocketed by 171bps to 2.25% in 2022, then dropped by -26bps to 1.67% in 2023, then plummeted by -587bps to 8.13% in 2024.
  • Its EBITDA Margin stands at 8.13% for FY2024, versus 1.67% for FY2023 and 2.25% for FY2022.